Onconetix Free Cash Flow (FCF) History (ONCO)

Onconetix reported −$10.5M in free cash flow for fiscal 2024, an increase of $3.1M from the previous fiscal year, with a free cash flow margin of −416.95%.

View full Onconetix company overview

Onconetix free cash flow by year

Onconetix annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$10.5M$3.1M−416.95%
20232023-12-31−$13.6M−$4.9M−23234.96%
20222022-12-31−$8.7M−$6.6M
20212021-12-31−$2.0M

Onconetix free cash flow growth trends

Onconetix's latest reported quarter, Q4 2024, generated −$921,521 in free cash flow, an increase of $3.4M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Onconetix filings at SEC.gov ↗